Clinical trial
Hypoglycemia Counterregulation and Symptom Perception With Insulin Detemir
NCT00490893 · University Hospital Tuebingen, Other · Terminated
Key facts
| NCT number | NCT00490893 |
|---|---|
| Title | Hypoglycemia Counterregulation and Symptom Perception With Insulin Detemir |
| Official title | Effects of Insulin Detemir Versus Regular Insulin (Actrapid) on Hormonal Counterregulation, Cognitive Function and Symptom Perception During Hypoglycemia |
| Lead sponsor | University Hospital Tuebingen, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Hypoglycemia |
| Intervention type | Drug |
| Interventions | Detemir |
| Enrollment | 12 |
| Start date | Mar 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Jun 25, 2007 |
| Last update posted | Jun 25, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: